Detalhe da pesquisa
1.
Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling.
Development
; 149(9)2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417019
2.
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.
Ann Hematol
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453703
3.
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective.
Nephrol Dial Transplant
; 38(2): 362-371, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238929
4.
Dose optimalization of subcutaneous ravulizumab is predicted to yield significant savings and to improve patient friendliness.
Br J Clin Pharmacol
; 89(3): 1211-1215, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394176
5.
The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway.
J Immunol
; 207(10): 2465-2472, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635587
6.
Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?
Kidney Int
; 101(6): 1107-1109, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597589
7.
Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.
Pediatr Nephrol
; 37(3): 601-612, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476601
8.
Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
N Engl J Med
; 389(15): 1402-1414, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819955
9.
Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome. Reply.
N Engl J Med
; 389(26): 2500, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157518
10.
The potential of individualized dosing of ravulizumab to improve patient-friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs.
Br J Clin Pharmacol
; 87(8): 3359-3363, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512711
11.
Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin.
Int J Mol Sci
; 22(11)2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070679
12.
Narrowing the knowledge gap in atypical HUS.
Blood
; 142(16): 1334-1335, 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856094
13.
Preparing for a kidney transplant: Medical nephrectomy in children with nephrotic syndrome.
Pediatr Transplant
; 24(4): e13703, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32212310
14.
Treatment-resistant nephrotic syndrome in dense deposit disease: complement-mediated glomerular capillary wall injury?
Pediatr Nephrol
; 35(9): 1791-1795, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32447506
15.
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
Pediatr Nephrol
; 34(11): 2261-2277, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30402748
16.
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
Pediatr Nephrol
; 34(4): 741-742, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30645679
17.
The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?
Pediatr Nephrol
; 34(8): 1349-1367, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141176
18.
Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157.
Pediatr Nephrol
; 34(4): 631-639, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367236
19.
Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.
Nephrol Dial Transplant
; 33(4): 635-645, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29106598
20.
Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy.
Pediatr Nephrol
; 33(10): 1701-1712, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974258